Skip to main content
OpenTrials
Active, not recruiting

NCT Number: NCT06754280

An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease

RESET-CKD is evaluating an intervention to support Black adults with chronic kidney disease (CKD) to reduce their sedentary (e.g., sitting) time. Half of the participants will be randomized to the intervention, where the goal is to support individuals to reduce their sitting time, and the other half will be randomized to an attention control condition that provides CKD-related education not related to sedentary behavior. All participants will be followed for 12 weeks.

Active, not recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Chronic Kidney Disease(CKD) Behavior Chronic Disease Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Sedentary Behavior Urogenital Diseases Urologic Diseases

Age range

35 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UI Health/University of Illinois Chicago

Chicago, Illinois, 60612, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Self-identifies as Black or African American
  • Age ≥35 to ≤80 years old
  • CKD Stage 1-4
  • Self-reported 6 or more hours/day of sedentary time
  • Ability to speak/read/understand English
  • Has access to a telephone

Exclusion criteria

  • Being unable to walk 1 block
  • Being unable to stand from a seated position without assistance
  • Using a wheelchair, walker, or cane for all of their ambulation
  • Presence of a condition(s) or diagnosis, either physical or psychological, that precludes participation, including: Lower-extremity amputation (AKA or BKA) without prosthetic, Orthopedic condition that would preclude prompted sit-to-stand transitions or standing, Neurologic or psychiatric condition that would preclude prompted sit-to- stand transitions or standing, Severe cognitive impairment, Unstable coronary artery disease (i.e., angina with activity), Orthostatic hypotension
  • Kidney transplant
  • Any other condition that the investigator considers precludes participation in the trial
  • Participated in the Patient Advisory Board

Treatment and study plan

RESET-CKD

Behavioral

RESET-CKD is a 12-week intervention that consists of four major components to support decreasing sedentary behavior: (1) health coaching, (2) feedback charts on sedentary behavior, (3) a workbook, and (4) reminders and cues.

Attention Control

Other

CKD-related education

Primary outcomes

  1. Change in sedentary time

    Time frame: Baseline to week 12

    Change in activPAL-measured sedentary time

Secondary outcomes

  1. Change in self-reported sedentary time

    Time frame: Baseline to week 12

    Change in self-reported sedentary time

  2. Change in health-related quality of life

    Time frame: Baseline to week 12

    Change in health-related quality of life measured via the KDQOL

Sponsors and collaborators

Lead sponsor

University of Illinois at Chicago

Other

Collaborators

  • National Institute of Nursing Research (NINR)

Registry information

Official study title

An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease: RESET-CKD

Acronym: RESET-CKD

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Dec 31, 2024
Registry last updated
Sep 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.